Ausgabe 12/2016
Inhalt (16 Artikel)
Optical Coherence Tomography Angiography in Diabetes
Jessica Lee, Richard Rosen
Biomarkers of Diabetic Retinopathy
Daniel Shu Wei Ting, Kara-Anne Tan, Val Phua, Gavin Siew Wei Tan, Chee Wai Wong, Tien Yin Wong
Clinical Components of Telemedicine Programs for Diabetic Retinopathy
Mark B. Horton, Paolo S. Silva, Jerry D. Cavallerano, Lloyd Paul Aiello
Operational Components of Telemedicine Programs for Diabetic Retinopathy
Mark B. Horton, Paolo S. Silva, Jerry D. Cavallerano, Lloyd Paul Aiello
Targeting Tie2 for Treatment of Diabetic Retinopathy and Diabetic Macular Edema
Peter A. Campochiaro, Kevin G. Peters
The Role of Retinal Imaging and Portable Screening Devices in Tele-ophthalmology Applications for Diabetic Retinopathy Management
Delia Cabrera DeBuc
Vascular Endothelial Growth Factor Inhibitors for Diabetic Retinopathy
Dilsher S. Dhoot, Robert L. Avery
Presence and Risk Factors for Glaucoma in Patients with Diabetes
Brian J. Song, Lloyd Paul Aiello, Louis R. Pasquale
Using Group Medical Visits With Those Who Have Diabetes: Examining the Evidence
Laura M. Housden, Sabrina T. Wong
Redesigning Diabetes Care: Defining the Role of Endocrinologists Among Alternative Providers
Samir Malkani, Sheri A. Keitz, David M. Harlan
MicroRNAs in Type 1 Diabetes: Complex Interregulation of the Immune System, β Cell Function and Viral Infections
Sonia R. Isaacs, Jie Wang, Ki Wook Kim, Congcong Yin, Li Zhou, Qing Sheng Mi, Maria E. Craig
Metabolomic Biomarkers in the Progression to Type 1 Diabetes
Anne Julie Overgaard, Simranjeet Kaur, Flemming Pociot
Prevention and Care Programs Addressing the Growing Prevalence of Diabetes in China
Junmei Yin, Alice P. S. Kong, Juliana C. N. Chan
Implications of the EMPA-REG Trial for Clinical Care and Research
Angeliki M. Stamatouli, Silvio E. Inzucchi
A Plethora of GLP-1 Agonists: Decisions About What to Use and When
Susan L. Samson, Alan J. Garber
Urogenital Autonomic Dysfunction in Diabetes
Barbara H. Braffett, Hunter Wessells, Aruna V. Sarma